These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 10715467
1. A prospective randomized study comparing poly-ATG to mono-OKT3 clonal antibodies for the first rejection therapy after kidney transplantation: long-term results. Baldi A, Malaise J, Mourad M, Squifflet JP. Transplant Proc; 2000 Mar; 32(2):429-31. PubMed ID: 10715467 [No Abstract] [Full Text] [Related]
3. Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center. Inui M, Tanabe K, Ishikawa N, Tokumoto T, Harano M, Otsubo S, Suzuki K, Goya N, Yagisawa T, Nakazawa H, Fuchinoue S, Toma H. Transplant Proc; 1999 Nov; 31(7):2870-1. PubMed ID: 10578320 [No Abstract] [Full Text] [Related]
5. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation. Uslu A, Tokat Y, Ok E, Unsal A, Ilkgul O, Kaplan H. Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571 [No Abstract] [Full Text] [Related]
6. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients. Mariat C, Alamartine E, Diab N, de Filippis JP, Laurent B, Berthoux F. Transpl Int; 1998 Nov; 11(3):231-6. PubMed ID: 9638854 [Abstract] [Full Text] [Related]
13. Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of the first acute cellular rejection of kidney allografts. Alamartine E, Bellakoul R, Berthoux F. Transplant Proc; 1994 Feb; 26(1):273-4. PubMed ID: 8108975 [No Abstract] [Full Text] [Related]
14. The fate of renal allografts treated with OKT3 for steroid-resistant rejection. Veronese FV, Gonçalves LF, Vilarinho LL, Macedo VS, Manfro RC. Transplant Proc; 1999 Nov; 31(7):3016-8. PubMed ID: 10578371 [No Abstract] [Full Text] [Related]
15. Antilymphocyte globulins versus OKT3 as prophylactic treatment in highly sensitized renal transplant recipients. Vela C, Cristol JP, Chong G, Okamba A, Lorho R, Mion C, Mourad G. Transpl Int; 1994 Nov; 7 Suppl 1():S259-62. PubMed ID: 11271219 [Abstract] [Full Text] [Related]